Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-027339
Filing Date
2025-02-26
Accepted
2025-02-26 08:00:31
Documents
106
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nams-20241231.htm   iXBRL 10-K 4577936
2 EX-4.4 nams-ex4_4.htm EX-4.4 113497
3 EX-10.11 nams-ex10_11.htm EX-10.11 274288
4 EX-10.12 nams-ex10_12.htm EX-10.12 35160
5 EX-10.13 nams-ex10_13.htm EX-10.13 88033
6 EX-10.16 nams-ex10_16.htm EX-10.16 42188
7 EX-19.1 nams-ex19_1.htm EX-19.1 95548
8 EX-23.1 nams-ex23_1.htm EX-23.1 7760
9 EX-31.1 nams-ex31_1.htm EX-31.1 19118
10 EX-31.2 nams-ex31_2.htm EX-31.2 19094
11 EX-32.1 nams-ex32_1.htm EX-32.1 10966
12 EX-32.2 nams-ex32_2.htm EX-32.2 10942
13 GRAPHIC img107864563_0.jpg GRAPHIC 42056
14 GRAPHIC img107864563_1.jpg GRAPHIC 71704
15 GRAPHIC img107864563_2.jpg GRAPHIC 89648
16 GRAPHIC img107864563_3.jpg GRAPHIC 662965
17 GRAPHIC img107864563_4.jpg GRAPHIC 116503
18 GRAPHIC img107864563_5.jpg GRAPHIC 76185
19 GRAPHIC img107864563_6.jpg GRAPHIC 69501
20 GRAPHIC img107864563_7.jpg GRAPHIC 61544
21 GRAPHIC img107864563_8.jpg GRAPHIC 134290
22 GRAPHIC img107864563_9.jpg GRAPHIC 70200
23 GRAPHIC img107864563_10.jpg GRAPHIC 16433
24 GRAPHIC img194721301_0.jpg GRAPHIC 506293
25 GRAPHIC img258693684_0.jpg GRAPHIC 4094
26 GRAPHIC img258693684_1.jpg GRAPHIC 4094
27 GRAPHIC img258693684_2.jpg GRAPHIC 4094
  Complete submission text file 0000950170-25-027339.txt   18124540

Data Files

Seq Description Document Type Size
28 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nams-20241231.xsd EX-101.SCH 1437614
109 EXTRACTED XBRL INSTANCE DOCUMENT nams-20241231_htm.xml XML 2085827
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41562 | Film No.: 25666221
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)